News

At some point within the first hour of waking up, expose yourself to natural light, preferably by taking a quick walk, Kaur ...
Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...
The cost of a new randomized trial to evaluate the vaccine’s ability to prevent disease could run into tens of millions of ...
Federal regulators are asking Novavax to complete an additional clinical trial on its Covid-19 vaccine after previously ...
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...
Rejoice, fellow vaccine enthusiasts-it looks like there's good news on the horizon for Novavax, everyone's favorite scrappy, ...
Whooping cough cases are rising, and doctors are bracing for yet another tough year. There have been 8,485 cases reported in ...
Shares of Novavax Inc. NVAX slid 5.35% to $7.07 Thursday, on what proved to be an all-around favorable trading session for ...
The Novavax COVID-19 vaccine is set to finally receive full approval from the FDA. The agency said Novavax must collect more ...
Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...